drugset / Trial / NCT00886470

ST266 Versus Standard Care In Treating Partial Thickness Burns

NCT00886470 ↗

Phase 1/2 Terminated 16 enrolled Noveome Biotherapeutics
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this protocol is to perform a safety and dose-determination efficacy clinical trial in patients having a degree of partial-thickness burn wounds. The trial will be a prospectively randomized and double-blind trial of ST266 compared with standardized care using 0.9% NaCl (normal saline) solution in the same three treatment regimens.

Timeline

Start
2009-06
Primary completion
2010-03
Completion
2010-03

Outcome

Outcome not reported

Stopped (Enrollment): “This study was terminated early due to slow accrual of patients.”

Drugs

EvaluationDrugModalityDoseRoute
Subject ST266 Protein / enzyme biologic 0.01 unknown Topical

Indications

No indication recorded.